Stockerau, Austria

Karl-Heinz Heider

USPTO Granted Patents = 14 



Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Karl-Heinz Heider: Pioneering Immunotherapies through Inventiveness

Introduction: Karl-Heinz Heider, a prolific inventor based in Stockerau, Austria, has made significant contributions to the field of immunotherapy with a total of 13 patents to his name.

Latest Patents: Among his latest patents are innovative CD33 binding agents, revolutionizing therapies for myeloid cell malignancies and myelodysplastic syndrome. Additionally, his work on anti-CD37 antibodies showcases his dedication to treating B cell malignancies and autoimmune diseases involving B cells.

Career Highlights: Heider has lent his expertise to renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc., where he played a pivotal role in developing groundbreaking pharmaceutical solutions.

Collaborations: Collaborating with esteemed professionals like Elinborg Ostermann and Eric Borges, Heider has showcased his ability to work synergistically to drive innovation in the medical field.

Conclusion: Karl-Heinz Heider's relentless pursuit of advancing immunotherapies underscores his commitment to improving healthcare outcomes and solidifies his place as a trailblazer in the realm of medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…